medigraphic.com
ISSN 0187-5337 (Print)
Instituto Nacional de Perinatología

2005, Number 3-4

<< Back Next >>

Perinatol Reprod Hum 2005; 19 (3-4)

Neonatal morbidity and mortality evaluation in the prenatal steroids use

Fernández-Carrocera LA, Curiel-León G, Delgadillo-Avendaño JM, Salinas-Ramírez V

Language: Spanish
References: 38
Page: 133-140
PDF size: 90.68 Kb.


ABSTRACT

Introduction: Prenatal steroids have been used to reduce the frequency of neonatal respiratory complications. 13 million of preterm births are reported annually. Nineteen point seven percent of the births at The National Institute of Perinatology in Mexico City are preterm. We want to know the risks of antenatal corticosteroid therapy in pregnant women with preterm labor.
Material and Methods: We conducted a retrospective study in a third level hospital between January first 2002 and December 31 2003. Neonates with gestational ages between 26 and 32 weeks whose mothers received one or more antenatal corticosteroids therapy schemes (2 doses of 12 mg of intramuscu-lar betametasone with 24 hour interval or 4 doses or 6 mg of intramuscular dexamethasone) were included.
Results: One hundred and eight clinical records were reviewed and divided into two different groups: Group I (n = 69) who received one antenatal steroid scheme and Group II (n = 39) with 2 or more antenatal steroids therapy schemes. Men gestational age was significantly lower, 28 weeks, in group I (p = 0.001). Premature rupture of membranes of 24 hour of duration or more was more frequent in group I and 65% of the neonates in this group required endotracheal intubation during neonatal reanimation and 59% of the neonates in group II. Required this maneuver. There was an increased risk of septicemia and death in group I. The principal cause of death in both groups was septic shock. The risk of death was higher in group I; OR 3.57 IC 95% 1.2,11.36.
Conclusion: According to this results we were no able te demonstrate that more than one maturation treatment schedule were benefitial in any way to the neonates.


REFERENCES

  1. Bolaños AR, Gorbea CV. Visión general del nacimiento pretérmino. En: Ahued AJR. Prematurez un enfoque perinatal. México: 1. Textos Mexicanos; 2004, p. 1-8.

  2. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoids treatment for prevention of respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515-25.

  3. Antenatal corticosteroids therapy of fetal maturation. ACOG, Committee Opinion. No. 210. Obstet Gynecol 1998; 92: 1-2.

  4. Murphy K, Aghajafari F. Single versus repetitive courses of corticosteroids: what do we know? Clin Obstet Gynecol 2003; 46: 161-73.

  5. Cázarez OM, Romero SE, Escobedo AF. Impacto del uso de esteroides antenatales sobre la morbilidad de neonatos prematuros eutróficos. Ginecol Obs Mex 2000; 68: 296-300.

  6. Ikegami M, Polk DH, Jobe AH, Newnham J, Sly P, Koham R. Effect of interval from fetal corticosteroids treatment to delivery on postnatal lung function of preterms lambs. J Appl Physiol 1996; 80: 591-7.

  7. Vélez GA. Esteroides antenatales para maduración pulmonar. ¿Curso único o cursos múltiples? Una pregunta aún vigente. Rev Colomb Obstet Ginecol 2004; 55: 308-14.

  8. Ikegami M, Jobe AH, Newnham J, Polk DH, Willet KE, Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med 1997; 156: 178-84.

  9. Jobe AH, Wada N, Berry LM, Ikigami M, Ervin MG. Single and repetitive maternal glucocorticoids exposure reduce fetal growth in seep. Am J Obstet Gynecol 1998; 178: 880-5.

  10. Uno H, Johmiller L, Thieme C, Kemnitz JW, Engle MJ, Roecker EB. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. Dev Brain Res 1990; 53: 157-67.

  11. Ballard R, Ballard PL. Commentaries: corticosteroids and respiratory distress syndrome: status 1979. Pediatrics 1979; 63: 163-5.

  12. Terrone DA, Smith LG Jr, Wolf EJ. Neonatal effects and serum cortisol levels after multiple courses of maternal corticosteroids. Obstet Gynecol 1997; 90: 819-23.

  13. Mathews SG. Antenatal glucocorticoids and programming of the developing CNS. Pediatr Res 2000; 47: 291-300.

  14. Modi N, Lewis H, Al-Naqeb N, Ajayi-Obe M, Doré C, Rutherford M. The effects of repeated antenatal glucocorticoids therapy on the developing brain. Pediatr Res 2001; 50: 581-5.

  15. Pratt L, Waschbusch L, Ladd W, Gangnon R, Hendricks S. Multiple vs. single betamethasone therapy: neonatal and maternal effects. J Reprod Med 1999; 44: 257-64.

  16. Collaborative group on antenatal steroid therapy: effects of antenatal dexamethasone administration in the infant: long term follow up. J Pediatr 1984; 104: 259-67.

  17. MacArthur B, Howie M, Dezoete J. School progress and cognitive development of 6-year old children whose mothers were treated antenatally with betamethasone. Pediatrics 1982; 70: 99-105.

  18. Smolders DH, Neuvel J, Schmand B. Physical development and medical history of children who were treated antenatally with corticoste-roids to prevent respiratory distress syndrome:10-12 year follow-up. Pediatrics 1990; 86: 65-70.

  19. Esplin M, Fausett M, Smith S. Multiple courses of antenatal steroids are associated with a delay in long term psychomotor development in children with birth weights £ 1500 grams. Am J Obstet Gynecol 2000; 182: 524-9.

  20. Spinillo A, Viazzo F, Colleoni R, Chiara A, Cerbo RM, Fazzi E. Two year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol 2004; 191: 217-24.

  21. French N, Hagan R, Evans S. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999; 180: 114-21.

  22. Shelton SD, Boggess KM, Murtha AP. Repeated fetal betamethasone treatment and birth weight and head circumference. Obstet Gynecol 2001; 97: 301-4.

  23. Guinn DA, Atkinson MW, Sillivan L, Lee MJ, Macgregor S, Parilla BV. Single versus weekly courses of antenatal corticosteroids for women at risk of preterm delivery. A ramdomized controlled trial. JAMA 2001; 286: 1581-7.

  24. Crowther CA, Harding J. Dosis repetidas de corticosteroides prenatales administradas a mujeres con riesgo de parto prematuro para la prevención de enfermedades respiratorias neonatales. (Revisión Cochrane traducida). En: La biblioteca Cochrane Plus 2005. No. 2. Oxford: Update software Ltd-.

  25. Walfisch A, Hallak M, Mazor M. Multiple courses of antenatal steroids: risk and benefits. Obstet Gynecol 2001; 98: 491-7.

  26. NIH Consensus. Development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. Effects of corticosteriods for fetal maturation on perinatal outcomes. JAMA 1995; 273: 413-8.

  27. Crowley PA. Prophylactic corticosteroids for preterm birth. (Cochrane review) In: The Cochrane Library, Issue 2. Oxford: Update Software; 2000.

  28. Elimian A, Verma U, Canterito J, Shah J, Visintainer P, Tejani N. Effectiveness of antenatal steroids in obstetric subgroups. Obstet Gynecol 1999; 93: 174-9.

  29. Abbasi S, Hirsch D, Davis J. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. Am J Obstet Gynecol 2000; 182: 1243-9.

  30. Gardner MO, Goldenberg RL, Gaudier FL. Predicting low Apgar scores of infants weighing less than 1000 g: the effect of corticosteroids. Obstet Gynecol 1995; 85: 170-4.

  31. Romero R, Sibai B, Caritis S. Antibiotic treatment of preterm labor with intact membranes: A multicenter, randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol 1993; 169: 764-74.

  32. Ghidini A, Salafia CM, Minior VK. Repetead course of steroids in preterm membrane rupture do not increase the risk of histologic chorioamnioitis. Am J Perinatol 1997; 14: 309-13.

  33. Bullard SR, Donahue Sp, Feman SS. The decreasing incidence and severity of retinopathy of prematurity. J Apos 1999; 3: 46-52.

  34. Dirnberger DR, Bradley AY, Gordon MC. Single versus repeated course antenatal corticosteroids: outcomes in singleton and multiple gestation pregnancies. Am J Perinatol 2001; 18: 267-77.

  35. Banks BA, Cnaan A, Morgan MA. Multiple courses of antenatal corticosteroids and outcome of premature neonates. Am J Obstet Gynecol 1999; 181: 709-17.

  36. Collaborative group on antenatal steroid therapy: Effects of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981; 141: 276-87.

  37. Silver RK, Vyskocil C, Solomon SL. Rando-mized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks gestation. J Obstet Gynecol 1996; 87: 683-91.

  38. Cooke R. Trends in incidence of cranial ultrasound lesions and cerebral palsy in very low birth weight infants 1982-1993. Arch Dis Child Fetal Neonatal 1999; 80: 115-7.




2020     |     www.medigraphic.com